NKTR-214
CA045-001
Phase 3 mab completed
Quick answer
NKTR-214 for Melanoma is a Phase 3 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Melanoma
- Phase
- Phase 3
- Modality
- mab
- Status
- completed